![Handbook of Research on Innovations in the Diagnosis and Treatment of Dementia by Bamidis, Panagiotis D., Tarnanas, Ioannis, Hadjileontiadis, Leontios, Tsolaki, Magda - Amazon.ae Handbook of Research on Innovations in the Diagnosis and Treatment of Dementia by Bamidis, Panagiotis D., Tarnanas, Ioannis, Hadjileontiadis, Leontios, Tsolaki, Magda - Amazon.ae](https://m.media-amazon.com/images/I/51lcU1ADCYL._AC_SY580_.jpg)
Handbook of Research on Innovations in the Diagnosis and Treatment of Dementia by Bamidis, Panagiotis D., Tarnanas, Ioannis, Hadjileontiadis, Leontios, Tsolaki, Magda - Amazon.ae
![Ioannis Tarnanas on Twitter: "John Baldoni from GSK describing their bold practice of publicing internal trial's datasets at the public domain. An admirable approach and a practice to be replicated! #PrecisionHealth… https://t.co/luozl6YMIO" Ioannis Tarnanas on Twitter: "John Baldoni from GSK describing their bold practice of publicing internal trial's datasets at the public domain. An admirable approach and a practice to be replicated! #PrecisionHealth… https://t.co/luozl6YMIO"](https://pbs.twimg.com/media/DUQsl_yVQAAEvpu.jpg:large)
Ioannis Tarnanas on Twitter: "John Baldoni from GSK describing their bold practice of publicing internal trial's datasets at the public domain. An admirable approach and a practice to be replicated! #PrecisionHealth… https://t.co/luozl6YMIO"
![PDF) Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study PDF) Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study](https://i1.rgstatic.net/publication/352721733_Using_a_Digital_Neuro_Signature_to_measure_longitudinal_individual-level_change_in_Alzheimer's_disease_the_Altoida_large_cohort_study/links/60d5447092851ca9448454f0/largepreview.png)
PDF) Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study
![Evaluation of Three State-of-the-Art Classifiers for Recognition of Activities of Daily Living from Smart Home Ambient Data – topic of research paper in Medical engineering. Download scholarly article PDF and read for Evaluation of Three State-of-the-Art Classifiers for Recognition of Activities of Daily Living from Smart Home Ambient Data – topic of research paper in Medical engineering. Download scholarly article PDF and read for](https://cyberleninka.org/viewer_images/451658/f/1.png)
Evaluation of Three State-of-the-Art Classifiers for Recognition of Activities of Daily Living from Smart Home Ambient Data – topic of research paper in Medical engineering. Download scholarly article PDF and read for
TOP 100 Swiss Startup Altoida Secures Investment From Hikma Ventures to Drive Better Clinical Outcomes For Brain Disease – Venturelab
EIT Health - Congratulations to Altoida for raising $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality. Altoida CSO – Dr. Ioannis Tarnanas was the
Altoida Chief Science Officer Ioannis Tarnanas to Keynote at Worldwebforum - Jan. 14, 2020 - Altoida
Altoida Chief Science Officer Ioannis Tarnanas to Keynote at Worldwebforum - Jan. 14, 2020 - Altoida
EIT Health - Ioannis Tarnanas is the winner of #EIT Innovators Award. He is CSO for Altoida- makers of ADPS, which can tell if someone will develop Alzheimer's disease within 6 years,
![Stream Ioannis Tarnanas: Atlantic Equity for Equity in Brain Health by Atlantic Fellows | Listen online for free on SoundCloud Stream Ioannis Tarnanas: Atlantic Equity for Equity in Brain Health by Atlantic Fellows | Listen online for free on SoundCloud](https://i1.sndcdn.com/artworks-000450356403-u4t16n-t500x500.jpg)